WallStSmart

The Cooper Companies, Inc (COO) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

The Cooper Companies, Inc stock (COO) is currently trading at $71.45. The Cooper Companies, Inc PE ratio is 35.07. The Cooper Companies, Inc PS ratio (Price-to-Sales) is 3.31. Analyst consensus price target for COO is $91.80. WallStSmart rates COO as Hold.

  • COO PE ratio analysis and historical PE chart
  • COO PS ratio (Price-to-Sales) history and trend
  • COO intrinsic value — DCF, Graham Number, EPV models
  • COO stock price prediction 2025 2026 2027 2028 2029 2030
  • COO fair value vs current price
  • COO insider transactions and insider buying
  • Is COO undervalued or overvalued?
  • The Cooper Companies, Inc financial analysis — revenue, earnings, cash flow
  • COO Piotroski F-Score and Altman Z-Score
  • COO analyst price target and Smart Rating
COO

The Cooper Companies, Inc

NASDAQHEALTHCARE
$71.45
$0.96 (1.36%)
52W$61.78
$89.83
Target$91.80+28.5%

📊 No data available

Try selecting a different time range

IV

COO Intrinsic Value Analysis for Value Investors

Benjamin Graham Formula · The Cooper Companies, Inc (COO)

Margin of Safety
+11.7%
Fair Value
COO Fair Value
$94.07
Graham Formula
Current Price
$71.45
$22.62 below fair value
Undervalued
Fair: $94.07
Overvalued
Price $71.45
Graham IV $94.07
Analyst $91.80

COO is trading near its Graham intrinsic value of $94.07, suggesting the stock is reasonably priced at current levels.

Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.

WallStSmart

Smart Analysis

The Cooper Companies, Inc (COO) · 10 metrics scored

Smart Score

63
out of 100
Grade: C+
Buy
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in market cap, operating margin, price/book. Concerns around return on equity. Fundamentals are solid but monitor weak areas for improvement.

The Cooper Companies, Inc (COO) Key Strengths (5)

Avg Score: 8.6/10
Institutional Own.Quality
105.88%10/10

105.88% of shares held by major funds and institutions

Market CapQuality
$13.75B9/10

Large-cap company with substantial market presence

Operating MarginProfitability
20.80%8/10

Strong operational efficiency: $21 kept per $100 revenue

Price/BookValuation
1.638/10

Trading at 1.63x book value, attractively priced

EPS GrowthGrowth
26.90%8/10

Strong earnings growth at 26.90% per year

Supporting Valuation Data

COO Target Price
$91.8
16% Upside

The Cooper Companies, Inc (COO) Areas to Watch (5)

Avg Score: 4.2/10
Return on EquityProfitability
4.87%1/10

Very low returns on shareholder equity

Revenue GrowthGrowth
6.20%4/10

Modest revenue growth at 6.20%

Profit MarginProfitability
9.67%4/10

Thin profit margins with limited profitability

PEG RatioValuation
1.826/10

Growth is fairly priced, not cheap, not expensive

Price/SalesValuation
3.316/10

Revenue is fairly priced at 3.31x sales

Supporting Valuation Data

P/E Ratio
35.07
Expensive
Trailing P/E
35.07
Expensive

The Cooper Companies, Inc (COO) Detailed Analysis Report

Overall Assessment

This company scores 63/100 in our Smart Analysis, earning a C+ grade. Out of 10 metrics analyzed, 5 register as strengths (avg 8.6/10) while 5 fall into concern territory (avg 4.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Institutional Own., Market Cap, Operating Margin. Valuation metrics including Price/Book (1.63) suggest the stock is attractively priced. Profitability is solid with Operating Margin at 20.80%. Growth metrics are encouraging with EPS Growth at 26.90%.

The Bear Case

The primary concerns are Return on Equity, Revenue Growth, Profit Margin. Some valuation metrics including PEG Ratio (1.82), Price/Sales (3.31) suggest expensive pricing. Growth concerns include Revenue Growth at 6.20%, which may limit upside. Profitability pressure is visible in Return on Equity at 4.87%, Profit Margin at 9.67%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 4.87% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 6.20% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a moderate-to-high risk investment. Strengths and concerns are roughly balanced. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Mixed fundamentals with both positives (Institutional Own., Market Cap) and negatives (Return on Equity, Revenue Growth). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

COO Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

COO's Price-to-Sales ratio of 3.31x trades at a deep discount to its historical average of 12.89x (3th percentile). The current valuation is 86% below its historical high of 23.76x set in Jul 2017, and 45% above its historical low of 2.28x in Nov 2008. Over the past 12 months, the PS ratio has compressed from ~4.1x as trailing revenue scaled faster than the stock price.

Compare COO with Competitors

Top MEDICAL INSTRUMENTS & SUPPLIES stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for The Cooper Companies, Inc (COO) · HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES

The Big Picture

The Cooper Companies, Inc operates as a stable business with moderate growth and solid fundamentals. Revenue reached 4.2B with 6% growth year-over-year. Profit margins are thin at 9.7%, typical for companies in this phase that are reinvesting heavily in growth.

Key Findings

Cash Flow Positive

Generating 159M in free cash flow and 261M in operating cash flow. Earnings are translating into actual cash generation.

Low Return on Equity

ROE of 4.9% suggests the company isn't efficiently converting equity into profits.

What to Watch Next

Margin expansion: can The Cooper Companies, Inc push profit margins above 15% as the business scales?

Debt management: total debt of 2.8B is significantly higher than cash (111M). Monitor refinancing risk.

Sector dynamics: monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive moves, and regulatory changes that could impact The Cooper Companies, Inc.

Bottom Line

The Cooper Companies, Inc offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions(41 last 3 months)

Total Buys
14
Total Sells
27

Data sourced from SEC Form 4 filings

Last updated: 10:05:45 AM

About The Cooper Companies, Inc(COO)

Exchange

NASDAQ

Sector

HEALTHCARE

Industry

MEDICAL INSTRUMENTS & SUPPLIES

Country

USA

The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California.

Visit The Cooper Companies, Inc (COO) Website
6101 BOLLINGER CANYON ROAD, SAN RAMON, CA, UNITED STATES, 94583